Cochrane Abstracts
Amantadine for dyskinesia in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Amantadine for Dyskinesia in Parkinson's Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434822/1/Amantadine_for_dyskinesia_in_Parkinson's_disease.
Amantadine for dyskinesia in Parkinson's disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/1/Amantadine_for_dyskinesia_in_Parkinson's_disease. Accessed November 4, 2025.
Amantadine for dyskinesia in Parkinson's disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/1/Amantadine_for_dyskinesia_in_Parkinson's_disease
Amantadine for Dyskinesia in Parkinson's Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 November 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/1/Amantadine_for_dyskinesia_in_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amantadine for dyskinesia in Parkinson's disease
ID - 434822
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434822/1/Amantadine_for_dyskinesia_in_Parkinson's_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
